AL-LAD (6-Allyl-6-nor-lysergic acid diethylamide) is a synthetic psychedelic of the lysergamide class.
AL-LAD was first investigated in 1984 by Andrew J. Hoffman and David Nichols as part of a series of LSD analogs and derivatives. AL-LAD was later documented by Alexander Shulgin in his book TiHKAL (“Tryptamines I Have Known and Loved”), in which it is described as “one of the several very potent compounds in a large series of nor-LSD analogues.”
AL-LAD is a semisynthetic alkaloid of the lysergamide family. AL-LAD is the structural analog of lysergic acid, with an N,N-diethylamide functional group bound to RN of the chemical structure. AL-LAD’s chemical structure also contains a bicyclic hexahydroindole fused to a bicyclic quinoline group.
AL-LAD does not contain a methyl group substituted at R6 of its nor-lysergic acid skeleton. (A methyl group is an alkyl derived from methane, containing one carbon atom bonded to three hydrogen atoms). This makes AL-LAD unlike its structurally-similar friend, LSD. Unlike LSD, AL-LAD is substituted at R6 with an allyl group. This allyl group comprises of a methylene bridge bound to a vinyl substituent.
AL-LAD is often sold alongside other lysergamides, similar in structure and function to LSD — such as 1P-LSD and ETH-LAD.
|Our AL-LAD Drop Bottles are strictly for laboratory use only and are not approved for human consumption. Any mention of dosage/feeding to humans or animals or anything consumption related is not acceptable.